Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK139 in Chronic Rhinosinusitis With Nasal Polyps
NCT07755371Phase 2Not yet recruiting
- Sponsor
- Akeso, Inc.
- Start
- Aug 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of AK139 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Akeso, Inc.. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
AK139
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07755371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755371.